Close
FINDING CURES TOGETHER<sup>SM</sup>

AACR Congratulates Newest National Academy of Sciences Members

5/5/2016

​PHILADELPHIA — The American Association for Cancer Research (AACR) congratulates its 10 members who have been elected to the National Academy of Sciences, including Fellows of the AACR Academy Anton Berns, PhD; Peter A. Jones, PhD, DSc; and Kenneth W. Kinzler, PhD.

Election to the National Academy of Sciences recognizes an individual’s distinguished and continuing achievements in original research. The Academy elected a total of 84 new members and 21 foreign associates from 14 countries this year.

The following AACR members were elected to the National Academy of Sciences:

• Anton Berns, PhD, FAACR, principal investigator, Netherlands Cancer Institute, Amsterdam; 

• Helen M. Blau, PhD, Donald E. and Delia B. Baxter Foundation professor, Baxter Laboratory for Stem Cell Biology, Stanford University School of Medicine, Stanford, California;

• Myles A. Brown, MD, professor of medicine, Harvard Medical School; and director, Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston;

• Raymond J. Deshaies, PhD, investigator, Howard Hughes Medical Institute; and professor, Division of Biology, California Institute of Technology, Pasadena;

• Peter A. Jones, PhD, FAACR, research director and chief scientific officer, Van Andel Research Institute, Grand Rapids, Michigan; and member of the AACR Board of Directors (1990-1993);

• Michael B. Kastan, MD, PhD, executive director, Duke Cancer Institute; professor of pharmacology and cancer biology, Duke University, Durham, North Carolina; and member of the AACR Board of Directors (1999-2002);

• Kenneth W. Kinzler, PhD, FAACR, professor of oncology; co-director, The Ludwig Center, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore; and member of the AACR Board of Directors (2008-2011);

• Hidde L. Ploegh, PhD, professor of biology and member, Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Cambridge;

• Gabriel A. Rabinovich, PhD, professor of immunotherapy, University of Buenos Aires, Argentina; and

• David M. Sabatini, MD, PhD, investigator, Howard Hughes Medical Institute; professor of biology and member, Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Cambridge.

For the entire list, please visit the Academy website.